» Authors » Eun-Sil Shelley Hwang

Eun-Sil Shelley Hwang

Explore the profile of Eun-Sil Shelley Hwang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 76
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Record S, Hwang E, Chiba A
Surg Oncol Clin N Am . 2023 Sep; 32(4):663-673. PMID: 37714635
DCIS detection has increased dramatically since the introduction of screening mammography. Current guidance concordant care recommends surgical intervention for all patients with DCIS, followed by radiation and/or endocrine therapy for...
2.
Moris D, Barfield R, Chan C, Chasse S, Stempora L, Xie J, et al.
Ann Surg . 2023 Apr; 278(6):873-882. PMID: 37051915
Objectives: To characterize and quantify accumulating immunologic alterations, pre and postoperatively in patients undergoing elective surgical procedures. Background: Elective surgery is an anticipatable, controlled human injury. Although the human response...
3.
Al Abo M, Gearhart-Serna L, Van Laere S, Freedman J, Patierno S, Hwang E, et al.
NPJ Breast Cancer . 2022 Jun; 8(1):73. PMID: 35697736
Aggressive breast cancer variants, like triple negative and inflammatory breast cancer, contribute to disparities in survival and clinical outcomes among African American (AA) patients compared to White (W) patients. We...
4.
Hou R, Mazurowski M, Grimm L, Marks J, King L, Maley C, et al.
IEEE Trans Biomed Eng . 2019 Sep; 67(6):1565-1572. PMID: 31502960
Objective: The goal of this study is to use adjunctive classes to improve a predictive model whose performance is limited by the common problems of small numbers of primary cases,...
5.
Tamirisa N, Williamson H, Thomas S, Westbrook K, Greenup R, Plichta J, et al.
J Surg Oncol . 2019 May; 120(2):132-141. PMID: 31062375
Background And Objectives: We sought to evaluate the impact of chemotherapy sequence on survival by comparing node-positive invasive lobular carcinoma (ILC) patients who received neoadjuvant (NACT) and adjuvant (ACT) chemotherapy....
6.
Saha A, Harowicz M, Cain E, Hall A, Hwang E, Marks J, et al.
Breast Cancer Res Treat . 2018 Jul; 172(1):123-132. PMID: 29992418
Purpose: The purpose of the study was to define quantitative measures of intra-tumor heterogeneity in breast cancer based on histopathology data gathered from multiple samples on individual patients and determine...
7.
Leraas H, Rosenberger L, Ren Y, Ezekian B, Nag U, Reed C, et al.
J Pediatr Surg . 2018 Apr; 53(6):1123-1128. PMID: 29605260
Background: Phyllodes tumors are fibroepithelial breast lesions that are uncommon in women and rare among children. Due to scarcity, few large pediatric phyllodes tumor series exist. Current guidelines do not...
8.
Ohri N, Sittig M, Tsai C, Hwang E, Mittendorf E, Shi W, et al.
Cancer . 2017 Nov; 124(3):482-490. PMID: 29112227
Background: High-level evidence is lacking to guide treatment decisions about postmastectomy radiation therapy (PMRT) in patients who have breast cancer with 1 to 3 positive lymph nodes who receive contemporary...
9.
Chen Y, Hwang E, Roy R, DeVries S, Anderson J, Wa C, et al.
Am J Surg Pathol . 2009 Aug; 33(11):1683-94. PMID: 19701073
The clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed...